Clinical potential of pulsating aerosol for sinus drug delivery

Expert Opinion on Drug Delivery

Volumn 7, Issue 11, 2010, Pages 1239-1245

  Möller, Winfried ^a   Mnzing, Wolfgang ^b   Canis, Martin ^b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Chronic rhinosinusitis; Clearance; Paranasal sinus ventilation; Pulsating aerosol; Topical therapy

Indexed keywords

AEROSOL; CHRONIC INFLAMMATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RETENTION; HUMAN; ISOTOPE LABELING; PARANASAL SINUS; PULSATILE FLOW; REVIEW; RHINOSINUSITIS;

ADMINISTRATION, INTRANASAL; AEROSOLS; CHRONIC DISEASE; DRUG DELIVERY SYSTEMS; HUMANS; PARANASAL SINUSES; PULSE THERAPY, DRUG; RHINITIS; SINUSITIS; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 77958561885     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.2010.523078     Document Type: Review

References (46)

1. Dykewicz MS, Hamilos DL. Rhinitis and sinusitis. J Allergy Clin Immunol 2010;125(2 Suppl 2):S103-15
2. Benninger MS. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 2003;129(3):S1-32
3. Fokkens W, Lund V, Mollol J. The European position paper on rhinosinusitis and nasal polyps (EP3OS) group. Rhinology 2007;45(Suppl 20):1-137
4. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg 2004;131(6):S1-62
5. Armengot M, Juan G, Barona R, et al. Immotile cilia syndrome: nasal mucociliary function and nasal ciliary abnormalities. Rhinology 1994;32(3):109-11
6. Leynaert B, Neukirch F, Demoly P, Bousquet J. Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol 2000;106(5):S201-5
7. Bachert C, Patou J, Van Cauwenberge P. The role of sinus disease in asthma. Curr Opin Allergy Clin Immunol 2006;6(1):29-36
8. Gosepath J, Mann WJ. Current concepts in therapy of chronic rhinosinusitis and nasal polyposis. ORL 2005;67(3):125-36
9. Hyo N, Takano H, Hyo Y. Particle deposition efficiency of therapeutic aerosols in the human maxillary sinus. Rhinology 1989;27(1):17-26
10. Suman JD. Nasal drug delivery. Expert Opin Biol Ther 2003;3(3):519-23
11. Maniscalco M, Sofia M, Weitzberg E, Lundberg JO. Sounding airflow enhances aerosol delivery into the paranasal sinuses. Eur J Clin Invest 2006;36(7):509-13
12. Kauf H. Eindringvermogen von Aerosolen in Nebenraume [Penetration ability of aerosols into secondary spaces]. Eur Arch Otorhinolaryngol 1968;190(1):95-108
13. Sanders M. Inhalation therapy: an historical review. Prim Care Respir J 2007;16(2):71-81
14. Hens G, Vanaudenaerde BM, Bullens DMA, et al. Sinonasal pathology in nonallergic asthma and COPD: 'united airway disease' beyond the scope of allergy. Allergy 2008;63(3):261-7
15. Bourdin A, Gras D, Vachier I, Chanez P. Upper airway. 1: allergic rhinitis and asthma: united disease through epithelial cells. Thorax 2009;64(11):999-1004
16. Toste JMG, Valles CP, Miret JMI. A united airway: bronchiectasis is also associated with chronic rhinosinusitis and nasal polyps. Arch Bronconeumol 2009;45(10):525-6
17. Joe SA, Thakkar K. Chronic rhinosinusitis and asthma. Otolaryngol Clin North Am 2008;41(2):297-309
18. Mainz JG, Koitschev A. Management of chronic rhinosinusitis in CF. J Cyst Fibros 2009;8:S10-14
19. Rogers DF. Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy. Monaldi Arch Chest Dis 2000;55(4):324-32
20. Puchelle E, Bajolet O, Abely M. Airway mucus in cystic fibrosis. Paediatr Respir Rev 2002;3(2):115-19
21. von Helmholtz H. Die Lehre von den Tonempfindungen als physiologische Grundlage fur die Theorie der Musik. Braunschweig, Germany: F. Vieweg; 1863
22. Guillerm R, Badre R, Flottes L, et al. Nouveau procede assurant la penetration des aerosols dans les sinus. [A new method of aerosol penetration into the sinuses.]. Presse Med 1959;67(27):1097-8
23. Sato Y, Hyo N, Sato M, et al. Intra-nasal distribution of aerosols with or without vibration. Z Erkr Atmungsorgane 1981;157(3):276-80
24. Pynnonen MA, Mukerji SS, Kim HM, et al. Nasal saline for chronic sinonasal symptoms - A randomized controlled trial. Arch Otolaryngol 2007;133(11):1115-20
25. Hwang PH, Woo RJ, Fong KJ. Intranasal deposition of nebulized saline: a radionuclide distribution study. Am J Rhinol 2006;20(3):255-61
26. Moller W, Schuschnig U, Khadem Saba G, et al. Pulsating aerosols for drug delivery to the sinuses in healthy volunteers. Otolaryngol Head Neck Surg 2010;142(3):382-8
27. Djupesland PG, Skretting A, Winderen M, Holand T. Breath actuated device improves delivery to target sites beyond the nasal valve. Laryngoscope 2006;116(3):466-72
28. ICRP Publication 66. Human respiratory tract model for radiological protection. A report of a Task Group of the International Commission on Radiological Protection. Ann ICRP 1994;24(1-3):1-482
29. Knoch M, Keller M. The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems. Expert Opin Drug Deliv 2005;2(2):377-90
30. Schuschnig U, Keller M, Klopfer E, et al. Drug delivery to the nasal and paranasal cavities - critical cast dimensions and aerosol dynamics. In: Dalby RN, Byron PR, Peart J, Suman JD, Farr SJ, Young PM, editors, Respiratory drug delivery 2008 Arizona. Virginia Commonwealth University, Scottsdale, Arizona, USA; 2008. p. 227-38
31. Wagner HN Jr. Regional ventilation and perfusion. In: Wagner HN, Szabo Z, Buchanan J, editors, Principles of nuclear medicine. 2nd edition. Saunders, Philadelphia; p. 887-95
32. Moller W, Schuschnig U, Meyer G, et al. Ventilation and aerosolized drug delivery to the paranasal sinuses using pulsating airflow - a preliminary study. Rhinology 2009;47(4):405-12
33. Moller W, Schuschnig U, Meyer G, et al. Ventilation and drug delivery to the paranasal sinuses: studies in a nasal cast using pulsating airflow. Rhinology 2008;46(3):213-20
34. Ragab SM, Lund VJ, Scadding G. Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial. Laryngoscope 2004;114(5):923-30
35. Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol 2005;116(6):1289-95
36. Fiocchi A, Sarratud T, Bouygue GR, et al. Topical treatment of rhinosinusitis. Pediatr Allergy Immunol 2007;18:62-7
37. Novembre E, Mori F, Pucci N, et al. Systemic treatment of rhinosinusitis in children. Pediatr Allergy Immunol 2007;18:56-61
38. Joe SA, Thambi R, Huang J. A systematic review of the use of intranasal steroids in the treatment of chronic rhinosinusitis. Otolaryngol Head Neck Surg 2008;139(3):340-7
39. Kalish LH, Arendts G, Sacks R, Craig JC. Topical steroids in chronic rhinosinusitis without polyps: a systematic review and meta-analysis. Otolaryngol Head Neck Surg 2009;141(6):674-83
40. Snidvongs K, Chaowanapanja P, Aeumjaturapat S, et al. Does nasal irrigation enter paranasal sinuses in chronic rhinosinusitis? Am J Rhinol 2008;22(5):483-6
41. Harvey RJ, Debnath N, Srubiski A, et al. Fluid residuals and drug exposure in nasal irrigation. Otolaryngol Head Neck Surg 2009;141(6):757-61
42. Maniscalco M, Weitzberg E, Sundberg J, et al. Assessment of nasal and sinus nitric oxide output using single- breath humming exhalations. Eur Respir J 2003;22(2):323-9
43. Molimard M. How to achieve good compliance and adherence with inhalation therapy. Curr Med Res Opin 2005;21:S33-7
44. Saijo R, Majima Y, Hyo N, Takano H. Particle deposition of therapeutic aerosols in the nose and paranasal sinuses after transnasal sinus surgery: a cast model study. Am J Rhinol 2004;18(1):1-7
45. Mainz J, Mentzel HJ, Schneider G, et al. Sinu-nasal inhalation of Dornase alfa in CF. Results of a double-blind placebo-controlled pilot trial. J Cyst Fibros 2008;7(Suppl 2):S27
46. Pynnonen MA, Kim HM, Terrell JE. Validation of the Sino-Nasal Outcome Test 20 (SNOT-20) domains in nonsurgical patients. Am J Rhinol Allergy 2009;23(1):40-5